Mar 1, 2023, 09:54 AM by

Mar 1, 2023, 09:53 AM by

Cardio Diagnostics Holdings Inc, an artificial intelligence-powered precision cardiovascular medicine company, announced the launch of PrecisionCHD™, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

Mar 1, 2023, 09:49 AM by

Linus Health, a digital health company focused on transforming brain health, today announced that Leah Ray has joined its executive leadership team as the company’s first Chief Customer Officer.

Mar 1, 2023, 09:47 AM by

mdgroup launches third fully compliant medical distribution centre in Europe. Amsterdam logistics centre Horreum strengthens links in the clinical trial supply chain, streamlines hybrid and DCT conduct, and creates remarkable patient experiences.

Feb 28, 2023, 09:54 AM by User Not Found

Bio-IT World | Andrew Hopkins, CEO and Executive Director of Exscientia, speaks with host Stan Gloss of BioTeam about Exscientia’s machine learning-based and model-driven approach to drug design, the connection between knowledge and efficiency in drug optimization projects, and its fourth platform-designed drug launch into the clinic.

Feb 28, 2023, 09:40 AM by

Feb 28, 2023, 09:40 AM by

Feb 28, 2023, 09:38 AM by

Feb 28, 2023, 09:37 AM by

Feb 28, 2023, 09:34 AM by

Kalderos Introduces New Product Suite to Better Serve Manufacturers Navigating Drug Discount Programs

Feb 28, 2023, 01:00 AM by User Not Found

Bio-IT World | Oxford Nanopore Technologies and the Tecan Group announced their collaboration on an automated NGS library preparation workflow, and released a technical note outlining a proof-of-concept use case where the Oxford Nanopore’s Ligation Sequencing Kit XL V14 processing multiple DNA samples on the Tecan DreamPrep NGS achieves high yield and raw read sequencing modal accuracy of Q20 (99%) and above.

Feb 27, 2023, 10:22 AM by

Feb 27, 2023, 10:21 AM by

Feb 27, 2023, 10:21 AM by

Feb 27, 2023, 10:16 AM by

Feb 23, 2023, 01:00 AM by User Not Found

Bio-IT World | Advanced machine learning provides objective tumor response assessments and unlocks novel biomarkers to predict patient outcomes; a comprehensive single-cell multi-omic solution enables the simultaneous exploration of the whole genome and whole mRNA transcriptome from the same single cell; cutting-edge generative AI models, proprietary wet-lab technologies, and a leading cancer biospecimen repository and molecular database identify new therapeutic candidates at accelerated speeds; and more.

Feb 22, 2023, 10:07 AM by

Pharma Targeting, the bespoke research house exclusively working with pharma and biotech service providers, is celebrating its 10-year anniversary in 2023. Launched as a small custom research agency - part of The Targeting Group - the company has grown exponentially in the past decade, with global offices now across the UK, Europe, Argentina and India, and employing nearly 300 people with a backbone of world class life science experts, business strategists and marketing consultants, along with 200 PhD analysts.

Feb 22, 2023, 10:06 AM by

RIM’s new Board of Directors elects Andrew Lin as the new Chairman of the Board and appoints Dr. Wen-Chyi Shyu as the new CEO

Feb 22, 2023, 10:05 AM by

Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona Specialist biometrics CRO are key sponsor and presenter at industry event to support continuous professional development in clinical data management

Feb 22, 2023, 01:00 AM by User Not Found

Bio-IT World | The gut microbiome has for the first time been linked to a causal role in endometriosis. Up to now, efforts to investigate the contributing factors have been focused primarily on genetic changes or epigenetic disorders and yet understanding of the underlying pathology remains largely a mystery.